USP17L10

gene
On this page

Summary

USP17L10 (ubiquitin specific peptidase 17 like family member 10, HGNC:44438) is a protein-coding gene on chromosome 4p16.1, encoding Ubiquitin carboxyl-terminal hydrolase 17-like protein 10 (C9JJH3). Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection. It is a selective cancer dependency (DepMap: 10.0% of cell lines).

Predicted to enable cysteine-type deubiquitinase activity. Predicted to be involved in regulation of apoptotic process and regulation of protein stability. Predicted to be located in endoplasmic reticulum. Predicted to be active in cytosol and nucleus.

Source: NCBI Gene 100287144 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 2 total
  • Cancer dependency (DepMap): dependent in 10.0% of screened cell lines
  • MANE Select transcript: NM_001256852

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:44438
Approved symbolUSP17L10
Nameubiquitin specific peptidase 17 like family member 10
Location4p16.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000231396
Ensembl biotypeprotein_coding
Entrez100287144

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000417945

RefSeq mRNA: 1 — MANE Select: NM_001256852 NM_001256852

CCDS: CCDS59454

Canonical transcript exons

ENST00000417945 — 1 exons

ExonStartEnd
ENSE0000175033092106579212249

Expression profiles

Bgee: expression breadth tissue_specific, 1 present calls, max score 37.20.

Top tissues by expression

131 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
colonic epitheliumUBERON:000039737.20gold quality
ganglionic eminenceUBERON:000402337.12gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
bone marrowUBERON:000237131.74gold quality
muscle tissueUBERON:000238531.06gold quality
sural nerveUBERON:001548830.93gold quality
stromal cell of endometriumCL:000225529.87gold quality
prefrontal cortexUBERON:000045129.04gold quality
tonsilUBERON:000237228.52gold quality
duodenumUBERON:000211428.14gold quality
liverUBERON:000210728.04gold quality
lymph nodeUBERON:000002927.57gold quality
islet of LangerhansUBERON:000000626.55gold quality
vermiform appendixUBERON:000115426.42gold quality
gall bladderUBERON:000211025.98gold quality
bloodUBERON:000017825.94silver quality
olfactory segment of nasal mucosaUBERON:000538625.89gold quality
placentaUBERON:000198725.81gold quality
urinary bladderUBERON:000125525.72gold quality
leukocyteCL:000073825.37gold quality
monocyteCL:000057625.15gold quality
muscle of legUBERON:000138324.85gold quality
primary visual cortexUBERON:000243624.61gold quality
superior frontal gyrusUBERON:000266124.08gold quality
frontal cortexUBERON:000187024.01gold quality
pancreasUBERON:000126423.89gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.08

Regulation

Is transcription factor: no

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 10.0% of screened cell lines.

Cross-species orthologs

0 orthologs

Paralogs (71): USP2 (ENSG00000036672), USP28 (ENSG00000048028), USP36 (ENSG00000055483), USP13 (ENSG00000058056), USP33 (ENSG00000077254), USP40 (ENSG00000085982), USP48 (ENSG00000090686), USP14 (ENSG00000101557), USP11 (ENSG00000102226), USP10 (ENSG00000103194), USP31 (ENSG00000103404), USP42 (ENSG00000106346), USP5 (ENSG00000111667), USP4 (ENSG00000114316), USP9Y (ENSG00000114374), USP34 (ENSG00000115464), USP35 (ENSG00000118369), USP45 (ENSG00000123552), USP22 (ENSG00000124422), USP9X (ENSG00000124486), USP6 (ENSG00000129204), USP29 (ENSG00000131864), USP26 (ENSG00000134588), USP30 (ENSG00000135093), USP15 (ENSG00000135655), USP37 (ENSG00000135913), USP44 (ENSG00000136014), USP20 (ENSG00000136878), USP8 (ENSG00000138592), USP3 (ENSG00000140455), USP21 (ENSG00000143258), USP43 (ENSG00000154914), USP25 (ENSG00000155313), USP16 (ENSG00000156256), USP24 (ENSG00000162402), USP1 (ENSG00000162607), USP49 (ENSG00000164663), USP38 (ENSG00000170185), USP50 (ENSG00000170236), USP47 (ENSG00000170242)

Protein

Protein identifiers

Ubiquitin carboxyl-terminal hydrolase 17-like protein 10C9JJH3 (reviewed: C9JJH3)

All UniProt accessions (1): C9JJH3

UniProt curated annotations — full annotation on UniProt →

Function. Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection.

Subcellular location. Nucleus. Endoplasmic reticulum.

Similarity. Belongs to the peptidase C19 family. USP17 subfamily.

RefSeq proteins (1): NP_001243781* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001394Peptidase_C19_UCHDomain
IPR018200USP_CSConserved_site
IPR028889USPDomain
IPR038765Papain-like_cys_pep_sfHomologous_superfamily
IPR050164Peptidase_C19Family

Pfam: PF00443

UniProt features (11 total): compositionally biased region 5, active site 2, region of interest 2, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-C9JJH3-F167.010.40

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (2): 334 (proton acceptor); 89 (nucleophile)

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-5689880Ub-specific processing proteases

MSigDB gene sets: 14 (showing top): GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL, GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY, chr4p16, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_REGULATION_OF_PROTEIN_STABILITY, GOBP_PROTEOLYSIS, GOMF_PEPTIDASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_PEPTIDASE_ACTIVITY, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, REACTOME_DEUBIQUITINATION, REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES, GOBP_REGULATION_OF_PROGRAMMED_CELL_DEATH, GOBP_PROTEIN_MODIFICATION_PROCESS, GOMF_DEUBIQUITINASE_ACTIVITY

GO Biological Process (4): proteolysis (GO:0006508), protein deubiquitination (GO:0016579), regulation of protein stability (GO:0031647), regulation of apoptotic process (GO:0042981)

GO Molecular Function (4): cysteine-type deubiquitinase activity (GO:0004843), peptidase activity (GO:0008233), cysteine-type peptidase activity (GO:0008234), hydrolase activity (GO:0016787)

GO Cellular Component (3): nucleus (GO:0005634), endoplasmic reticulum (GO:0005783), cytosol (GO:0005829)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Deubiquitination1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular membrane-bounded organelle2
cytoplasm2
protein metabolic process1
cysteine-type deubiquitinase activity1
protein modification by small protein removal1
regulation of biological quality1
apoptotic process1
regulation of programmed cell death1
cysteine-type peptidase activity1
deubiquitinase activity1
hydrolase activity1
catalytic activity, acting on a protein1
peptidase activity1
catalytic activity1
endomembrane system1
cellular anatomical structure1

Protein interactions and networks

STRING

76 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
USP17L10NUP37Q8NFH4399
USP17L10LAMTOR1Q6IAA8324
USP17L10MACROH2A1O75367303
USP17L10SEPTIN9Q9UHD8252
USP17L10RPRD1BQ9NQG5222
USP17L10COQ9O75208185
USP17L10NDUFB10O96000174
USP17L10MCM2P49736167
USP17L10ATP5MEP56385167
USP17L10UQCRBP14927167
USP17L10NDUFB5O43674166
USP17L10TWF1Q12792160
USP17L10DCTN2Q13561157
USP17L10ATP5PDO75947147
USP17L10NOP2P46087146

IntAct

2 interactions, top by confidence:

ABTypeScore
Mpsi-mi:“MI:0914”(association)0.350

BioGRID (3): USP17L29 (Negative Genetic), USP17L10 (Affinity Capture-MS), USP17L10 (Affinity Capture-MS)

ESM2 similar proteins: A2A5N8, A6NCW0, A6NCW7, A8MUK1, B1AQJ2, B2RQC2, C9J2P7, C9JJH3, C9JLJ4, C9JPN9, C9JVI0, D3ZWK4, D6R901, D6R9N7, D6RA61, D6RBM5, D6RBQ6, D6RCP7, D6RJB6, E9Q9U0, G5E8G2, G5E8I7, O94966, P0C7H9, P0C7I0, P35125, P51784, Q0E2F9, Q0WX57, Q2TAC6, Q3UJD6, Q4KLL9, Q5R7G8, Q5TKR9, Q61068, Q66HE5, Q6J1Y9, Q6PFD6, Q6QN14, Q6R6M4

Diamond homologs: A1L1K8, A6NCW0, A6NCW7, A8MUK1, C9J2P7, C9JJH3, C9JLJ4, C9JPN9, C9JVI0, D6R901, D6R9N7, D6RA61, D6RBQ6, D6RCP7, D6RJB6, G1SW77, P0C7H9, P0C7I0, Q0WX57, Q5JVS0, Q5XJA5, Q6AXS5, Q6NRY1, Q6PB22, Q6R6M4, Q7RTZ2, Q8NC51, Q9CY58, Q9I9R0, Q9JKS5, A0JM59, A5PMR2, A5PN09, A6H8I0, A6NNY8, A6QNM7, A7Z056, B1AY13, B1WBD7, D3ZJ96

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

2 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

57 predictions. Top by Δscore:

VariantEffectΔscore
4:9211948:A:Tdonor_gain0.6300
4:9212021:CGAAG:Cdonor_loss0.6000
4:9212023:AAGG:Adonor_loss0.6000
4:9212024:AG:Adonor_loss0.6000
4:9212025:GGT:Gdonor_loss0.6000
4:9212026:GTAC:Gdonor_loss0.6000
4:9212027:T:Gdonor_loss0.5900
4:9210771:G:GCacceptor_gain0.5500
4:9211947:G:GTdonor_gain0.5400
4:9210770:TGAGA:Tacceptor_gain0.4900
4:9212022:GAAG:Gdonor_gain0.4900
4:9210770:TG:Tacceptor_gain0.4700
4:9210770:T:TAacceptor_gain0.4600
4:9211930:TGGA:Tdonor_gain0.4400
4:9212026:G:GGdonor_gain0.4400
4:9211755:GCC:Gdonor_gain0.4100
4:9212128:CGACG:Cacceptor_gain0.3700
4:9212020:TCGAA:Tdonor_loss0.3500
4:9212028:A:Cdonor_loss0.3500
4:9212129:GACGA:Gacceptor_gain0.3500
4:9211433:G:Cacceptor_gain0.3300
4:9211774:T:Gacceptor_gain0.3200
4:9211773:A:AGacceptor_gain0.3000
4:9211860:C:Tdonor_gain0.3000
4:9211874:A:Tdonor_gain0.3000
4:9212071:A:Gacceptor_gain0.3000
4:9212127:TCGAC:Tacceptor_gain0.3000
4:9211777:A:AGacceptor_gain0.2800
4:9211778:G:GGacceptor_gain0.2800
4:9211778:GAAGA:Gacceptor_gain0.2800

AlphaMissense

3497 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
4:9211503:T:CF283L0.904
4:9211505:C:AF283L0.904
4:9211505:C:GF283L0.904
4:9211146:T:CF164L0.901
4:9211148:T:AF164L0.901
4:9211148:T:GF164L0.901
4:9211418:T:GC254W0.892
4:9211417:G:AC254Y0.891
4:9211416:T:AC254S0.884
4:9211417:G:CC254S0.884
4:9211113:T:CF153L0.873
4:9211115:C:AF153L0.873
4:9211115:C:GF153L0.873
4:9211425:T:CC257R0.873
4:9211427:T:GC257W0.873
4:9211416:T:CC254R0.871
4:9211425:T:AC257S0.865
4:9211426:G:CC257S0.865
4:9211417:G:TC254F0.842
4:9211426:G:AC257Y0.837
4:9211692:T:AW346R0.837
4:9211692:T:CW346R0.837
4:9211767:T:CF371L0.837
4:9211769:T:AF371L0.837
4:9211769:T:GF371L0.837
4:9211245:T:CF197L0.819
4:9211247:T:AF197L0.819
4:9211247:T:GF197L0.819
4:9211155:T:CF167L0.813
4:9211157:C:AF167L0.813

dbSNP variants (sampled 300 via entrez): RS1051690168 (4:9209893 A>G), RS1157038845 (4:9211961 C>A), RS1157285748 (4:9210927 G>A), RS1157491888 (4:9209338 C>A,G), RS1157644284 (4:9210607 G>C,T), RS1158782506 (4:9211695 T>A,G), RS1158816961 (4:9211117 A>G), RS1160644305 (4:9211124 C>A), RS1160739567 (4:9212492 T>A), RS1161032231 (4:9211351 G>GCTGTCTC), RS1161254663 (4:9210920 C>A,T), RS1161368102 (4:9208677 C>A), RS1161470519 (4:9212677 G>A,C), RS1161920816 (4:9212365 A>G), RS1162024719 (4:9210648 C>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

2 total (human), top 2 by PubMed support.

ChemicalActions (top 5)PubMed papers
2-methyl-4-isothiazolin-3-oneincreases expression1
2-palmitoylglycerolincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.